Jodi B Segal

17.7k total citations · 4 hit papers
247 papers, 12.4k citations indexed

About

Jodi B Segal is a scholar working on Economics and Econometrics, Cardiology and Cardiovascular Medicine and General Health Professions. According to data from OpenAlex, Jodi B Segal has authored 247 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Economics and Econometrics, 44 papers in Cardiology and Cardiovascular Medicine and 41 papers in General Health Professions. Recurrent topics in Jodi B Segal's work include Health Systems, Economic Evaluations, Quality of Life (48 papers), Venous Thromboembolism Diagnosis and Management (37 papers) and Atrial Fibrillation Management and Outcomes (25 papers). Jodi B Segal is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (48 papers), Venous Thromboembolism Diagnosis and Management (37 papers) and Atrial Fibrillation Management and Outcomes (25 papers). Jodi B Segal collaborates with scholars based in United States, Vietnam and Japan. Jodi B Segal's co-authors include Eric B Bass, Sunny Dzik, Catalina Suarez‐Cuervo, Hsien‐Yen Chang, Renée F Wilson, Sara N. Bleich, Albert W. Wu, Neil R. Powe, Jonathan P. Weiner and Thomas M. Richards and has published in prestigious journals such as JAMA, Circulation and Journal of Clinical Oncology.

In The Last Decade

Jodi B Segal

241 papers receiving 12.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oral Direct-Acting Agent Therapy for Hepatitis C Virus Infection

2017 504 citations Catalina Suarez‐Cuervo, Jodi B Segal et al. Annals of Internal Medicine profile →
Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes

2016 495 citations Nisa M. Maruthur, Eva Tseng et al. Annals of Internal Medicine profile →
Paucity of studies to support that abnormal coagulation test results predict bleeding in the setting of invasive procedures: an evidence‐based review

2005 487 citations Jodi B Segal et al. profile →
What childhood obesity prevention programmes work? A systematic review and meta‐analysis

2015 413 citations Sara N. Bleich, Jodi B Segal et al. profile →

Peers

Countries citing papers authored by Jodi B Segal

Since Specialization

Citations

This map shows the geographic impact of Jodi B Segal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jodi B Segal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jodi B Segal more than expected).

Fields of papers citing papers by Jodi B Segal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jodi B Segal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jodi B Segal. The network helps show where Jodi B Segal may publish in the future.

Co-authorship network of co-authors of Jodi B Segal

This figure shows the co-authorship network connecting the top 25 collaborators of Jodi B Segal. A scholar is included among the top collaborators of Jodi B Segal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jodi B Segal. Jodi B Segal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Population‐Based Validation Results From the Drug Repurposing for Effective Alzheimer's Medicines (DREAM) Study 2025 ·Clinical Pharmacology & Therapeutics ·Rishi Desai, Vijay R. Varma, Mufaddal Mahesri, Su Been Lee, Arnold S. Freedman, Tobias Gerhard, Jodi B Segal, Seanna Vine, Mary B. Ritchey, Daniel B. Horton, Madhav Thambisetty	1
2	Addressing Missingness in Predictive Models That Use Electronic Health Record Data 2025 ·Annals of Internal Medicine ·(unknown), Rolf H. H. Groenwold, Hemalkumar B. Mehta, Ji Soo Kim, Jodi B Segal	0
3	Reducing Overuse by Healthcare Systems: A Positive Deviance Analysis 2023 ·Journal of General Internal Medicine ·Michael Ellenbogen, (unknown), J. Matthew Austin, Nancy L. Schoenborn, (unknown), Jodi B Segal	4
4	Comparative efficacy of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: A Bayesian network meta-analysis 2022 ·Journal of Allergy and Clinical Immunology ·Ayobami Akenroye, (unknown), John W. Jackson, Corinne Keet, Jodi B Segal, G. Caleb Alexander, Hwanhee Hong	47
5	Improving precision and power in randomized trials for COVID‐19 treatments using covariate adjustment, for binary, ordinal, and time‐to‐event outcomes 2020 ·Biometrics ·David Benkeser, Iván Díaz, Alex Luedtke, Jodi B Segal, Daniel O. Scharfstein, Michael Rosenblum	42
6	Characteristics of registered clinical trials assessing treatments for COVID-19: a cross-sectional analysis 2020 ·BMJ Open ·Hemalkumar B. Mehta, Stephan Ehrhardt, Thomas J. Moore, Jodi B Segal, G. Caleb Alexander	33
7	Dipeptidyl peptidase-4 inhibitors and cardiovascular events in patients with type 2 diabetes, without cardiovascular or renal disease 2020 ·PLoS ONE ·Sheriza Baksh, Jodi B Segal, Mara McAdams‐DeMarco, Rita R. Kalyani, G. Caleb Alexander, Stephan Ehrhardt	6
8	Association Between Filgrastim Biosimilar Availability and Changes in Claim Payments and Patient Out-of-Pocket Costs for Biologic Filgrastim Products 2020 ·Value in Health ·(unknown), Antonio J. Trujillo, G. Caleb Alexander, Jodi B Segal	10
9	Factors associated with potentially inappropriate medication use in community-dwelling older adults in the United States: a systematic review† 2019 ·International Journal of Pharmacy Practice ·Stephanie Nothelle, Ritu Sharma, Allison H. Oakes, (unknown), Jodi B Segal	56
10	Cardiovascular safety signals with dipeptidyl peptidase‐4 inhibitors: A disproportionality analysis among high‐risk patients 2018 ·Pharmacoepidemiology and Drug Safety ·Sheriza Baksh, Mara McAdams‐DeMarco, Jodi B Segal, G. Caleb Alexander	12
11	Nine years of comparative effectiveness research education and training: initiative supported by the PhRMA Foundation 2018 ·Publisher ·Emily Beth Devine, Eleanor M. Perfetto, A. Simon Pickard, Glen T. Schumock, Jodi B Segal, (unknown), Jean Paul Gagnon, Diana Brixner, Louis P. Garrison, Michael D. Murray	0
12	Warfarin use and the risk of stroke, bleeding, and mortality in older adults on dialysis with incident atrial fibrillation 2017 ·Nephrology ·Jingwen Tan, Sunjae Bae, Jodi B Segal, Junya Zhu, G. Caleb Alexander, Dorry L. Segev, Mara McAdams‐DeMarco	22
13	Comparative Effectiveness of Preoperative Paravertebral Block for Post-Mastectomy Reconstruction: A Systematic Review of the Literature 2017 ·Annals of Surgical Oncology ·Anaeze C. Offodile, Mario A. Aycart, Jodi B Segal	14
14	Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes 2016 ·Annals of Internal Medicine ·Nisa M. Maruthur, Eva Tseng, Susan Hutfless, Lisa M Wilson, Catalina Suarez‐Cuervo, Zackary Berger, Yue Chu, Emmanuel Iyoha, Jodi B Segal, Shari Bolen	12
15	Venous thromboembolism prophylaxis in patients with traumatic brain injury: a systematic review 2013 ·F1000Research ·Yohalakshmi Chelladurai, Kent A. Stevens, Elliott R. Haut, Daniel J. Brotman, Ritu Sharma, Kenneth M. Shermock, Sosena Kebede, Sonal Singh, Jodi B Segal	11
16	Predicting costs with diabetes complications severity index in claims data. 2012 ·PubMed ·Hsien‐Yen Chang, Jonathan P. Weiner, Thomas M. Richards, Sara N. Bleich, Jodi B Segal	38
17	Venous Thromboembolism after Total Hip and Knee Replacement in Older Adults with Single and Co-Occurring Comorbidities 2010 ·Cleveland Clinic Journal of Medicine ·Alok Kapoor, (unknown), Michael Winter, Jodi B Segal, Rebecca A. Silliman, Jeffrey N. Katz, Elena Losina, Dan R. Berlowitz	1
18	Upregulation of MMP-2 by HMGA1 Promotes Transformation in Undifferentiated, Large-Cell Lung Cancer 2009 ·Molecular Cancer Research ·Jöelle Hillion, Lisa J. Wood, Mita Mukherjee, Raka Bhattacharya, Francescopaolo Di Cello, Jeanne Kowalski, (unknown), Jodi B Segal, John T. Poirier, Charles M. Rudin, Surajit Dhara, Amy Belton, Biju Joseph, Stanley Zucker, Linda Resar	66
19	Treatment of venous thromboembolism with low-molecular-weight heparin: a synthesis of the evidence published in systematic literature reviews 2004 ·Respiratory Medicine ·(unknown), Jodi B Segal, Michael B. Streiff, Dennis Thomas Bolger, John Eng, Mollie W. Jenckes, Leonardo Tamariz, Eric B Bass	10
20	Diagnosis and treatment of deep venous thrombosis and pulmonary embolism. 2003 ·PubMed ·Jodi B Segal, John Eng, Mollie W. Jenckes, Leonardo Tamariz, Dennis Thomas Bolger, Jerry A. Krishnan, Michael B. Streiff, (unknown), Carolyn J Feuerstein, Eric B Bass	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact